ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Mind Medicine MindMed Inc

Mind Medicine MindMed Inc (MNMD)

9.50
-0.36
(-3.65%)
Closed March 27 04:00PM
9.50
0.00
( 0.00% )
Pre Market: 07:42AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
9.50
Bid
9.55
Ask
9.85
Volume
243
0.00 Day's Range 0.00
2.41 52 Week Range 11.10
Market Cap
Previous Close
9.50
Open
-
Last Trade
35
@
9.51
Last Trade Time
07:40:41
Financial Volume
-
VWAP
-
Average Volume (3m)
2,015,879
Shares Outstanding
41,334,307
Dividend Yield
-
PE Ratio
-0.03
Earnings Per Share (EPS)
-2.32
Revenue
-
Net Profit
-95.73M

About Mind Medicine MindMed Inc

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances inclu... Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies. Show more

Sector
Pharmaceutical Preparations
Industry
Unit Inv Tr, Closed-end Mgmt
Website
Headquarters
Vancouver, British Columbia, Can
Founded
2013
Mind Medicine MindMed Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MNMD. The last closing price for Mind Medicine MindMed was $9.50. Over the last year, Mind Medicine MindMed shares have traded in a share price range of $ 2.41 to $ 11.10.

Mind Medicine MindMed currently has 41,334,307 shares outstanding. The market capitalization of Mind Medicine MindMed is $2.89 million. Mind Medicine MindMed has a price to earnings ratio (PE ratio) of -0.03.

MNMD Latest News

Form 8-K - Current report

false 0001813814 0001813814 2024-03-07 2024-03-07   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORTPursuant to...

MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health...

Form 8-K - Current report

false 0001813814 0001813814 2024-03-07 2024-03-07   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORTPursuant to...

Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health...

Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]

As filed with the Securities and Exchange Commission on March 7, 2024 Registration No. 333-       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Form 8-K - Current report

false 0001813814 0001813814 2024-03-07 2024-03-07   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORTPursuant to...

MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder

-A single oral administration of MM120 100 µg met its key secondary endpoint and maintained a clinically and statistically significant HAM-A reductions compared to placebo at 12 weeks with a 65...

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">144: Remarks and SignatureRemarksDate of Notice03/01/2024ATTENTION: The person for whose account the securities to which this notice relates are...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.52-5.1896207584810.0210.849.3327336929.90235819CS
44.0173.04189435345.4911.15.4744899569.01004738CS
125.9163.8888888893.611.13.4920158797.95767775CS
265.98169.8863636363.5211.12.4112064946.89222159CS
526.59226.46048112.9111.12.418539816.01681872CS
156-75.8005-88.862902327785.300586.552.12330841428.06543821CS
260-75.8005-88.862902327785.300586.552.12330841428.06543821CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
XLOXilio Therapeutics Inc
$ 2.78
(335.05%)
118.69k
AVTXAvalo Therapeutics Inc
$ 20.04
(321.89%)
1.09M
BCGBinah Capital Group Inc
$ 18.94
(99.37%)
159.51k
PIKKidpik Corporation
$ 5.52
(68.81%)
1.71M
PEGRProject Energy Reimagined Acquisition Corporation
$ 11.58
(33.72%)
345
NCNANuCana PLC
$ 0.2437
(-20.53%)
55.32k
WAVDWaveDancer Inc
$ 2.93
(-18.61%)
10
INOInovio Pharmaceuticals Inc New
$ 10.65
(-18.27%)
99
SOBRSOBR Safe Inc
$ 0.41
(-18.00%)
1.49k
MLKNMillerKnoll Inc
$ 25.19
(-17.49%)
14.78k
KTRAKintara Therapeutics Inc
$ 0.1065
(18.99%)
13.16M
AKBAAkebia Therapeutics Inc
$ 2.68
(19.64%)
6.1M
CISSC3is Inc
$ 0.0344
(-9.95%)
3.53M
GMDAGamida Cell Ltd
$ 0.05
(-15.54%)
2.73M
PIKKidpik Corporation
$ 5.55
(69.72%)
1.71M

MNMD Discussion

View Posts
moondogaz moondogaz 9 hours ago
Only stupid people say others are stupid......
👍️0
Savannah-Marc Savannah-Marc 11 hours ago
Look up what Karuna Therapeutics got bought out for, makes $40 a share look like chump change!!!
👍️ 1 🤩 1
OmegaMoney29 OmegaMoney29 13 hours ago
Going 40$ soon 🔜 💥
🌋 1 👍️ 1
Savannah-Marc Savannah-Marc 21 hours ago
I agree, the only thing that is going to move the share price now is bigger money like companies and institutions. I think the role of retail investors is limited at this point. All the catalysts are in place for deep pockets to swoop in!
👍️ 1 🤩 1
burner67 burner67 1 day ago
Why do you make these stupid predictions all the time? You're looking foolish.
👍️0
LORTAP KCOTS LORTAP KCOTS 2 days ago
I think we are trading in this range for a while
👍️ 1 🤔 1
Savannah-Marc Savannah-Marc 2 days ago
You'll have to email me, check my profile
👍️ 1 🫡 1
Tiger Money Tiger Money 2 days ago
Got it. Will look at begi. My other big one is AGSS. Quiet before the storm
👍️ 1 🫡 1
Savannah-Marc Savannah-Marc 2 days ago
That POS followed me over here from BEGI, my other big position, when MNMD goes ballistic and or recieves a buyout, I committed my MNMD gains to buying up BEGI.
👍️ 1 🚀 1 🤡 1
Tiger Money Tiger Money 2 days ago
That was yday….
👍️ 1 🫡 1
burner67 burner67 2 days ago
Nope
👍️0
Savannah-Marc Savannah-Marc 3 days ago
Awesome close today! This will start to hold above $11 very soon!!!
👍️ 1 📈 1 🤣 1
Tiger Money Tiger Money 3 days ago
Very nice
👍️ 1 🫡 1
Savannah-Marc Savannah-Marc 3 days ago
Somebody bought big today! Big block buyer out there, I like their style!
👍️ 1 📈 1
Tiger Money Tiger Money 3 days ago
Agreed. Friday was a disappointment
👍️ 1 🫡 1
Savannah-Marc Savannah-Marc 3 days ago
Close at $11+ today.......
👍️ 1 📈 1
Savannah-Marc Savannah-Marc 3 days ago
I didn't catch that one, it could've been a fat finger mistake. If it wasn't, I'm not sure it would surge the price high enough to incur a halt...I could be wrong though lol...
👍️ 1 📈 1
OmegaMoney29 OmegaMoney29 3 days ago
That 200 k buy in 1 go
👍️ 1 📈 1
Savannah-Marc Savannah-Marc 3 days ago
What makes you say that???
👍️ 1 🤔 1
OmegaMoney29 OmegaMoney29 3 days ago
Halt up coming
🤔 1 ⁉️ 1
Savannah-Marc Savannah-Marc 3 days ago
This should be an exciting week, we're undervalued at this point by a factor of 3!!! I think this week should build up the share price quite considerably!!!
👍️ 1 📈 1
Tiger Money Tiger Money 6 days ago
I had a feeling we would drop below ten. Great day even though we were up about 10% most of the day. We pushed higher which is great
👍️ 1 🫡 1
Savannah-Marc Savannah-Marc 6 days ago
I thought we we're gonna break $11, let see what after hours does, I'm not concerned, we're still undervalued in my opinion by a multiple of 3!
👍️ 1 📈 1 🤣 1
Tiger Money Tiger Money 6 days ago
Tho k we will close above 10?
👍️ 1 🤔 1
Savannah-Marc Savannah-Marc 6 days ago
Yes Sir! Been here since Toronto and hoping to end up in Croatia!!!
👍️ 1 📈 1
Tiger Money Tiger Money 6 days ago
Long and strong
👍️ 1 🫡 1
Savannah-Marc Savannah-Marc 6 days ago
With going into Phase 3 and having FDA Breakthrough designation, this stock should be wayyyyyyy more appropriately valued at $27+ per share!!!!!!! Bigger money is coming!!!
🌋 1 👍️ 1 🤡 1
Tiger Money Tiger Money 6 days ago
Great analogy
👍️ 1 📈 1
LORTAP KCOTS LORTAP KCOTS 1 week ago
$10 is a great area, looks cheap to retail investors and is expensive enough for institutional investors.
👍️ 1 🥇 1
MomsSpaghetti MomsSpaghetti 1 week ago
Will win over time.
👍️ 1
Savannah-Marc Savannah-Marc 1 week ago
MNMD seems to like hovering in the approxomate $10 range for the time being. I think it is still vastly vastly undervalued!
👍️ 1 📈 1 🤡 1
Monksdream Monksdream 1 week ago
In the majority of cases, it’s the institutional players, due to their access to larger sources of capital, that provide bid support
👍️ 1 🚀 1
Nosnibor Nosnibor 2 weeks ago
Agreed. This is unquestionably a buy & hold stock.
👍️ 1 🥇 1
Savannah-Marc Savannah-Marc 2 weeks ago
Big money and institutions are coming back in, nothing better for both the stock price and shareholder value!!! With the FDA Breakthrough designation and entrance into Phase 3, MindMed should have a bare minimum market cap of $1.7 billion dollars. MNMD is wayyyyyyy undervalued at this stage!!!!!!!
👍️ 1 💰️ 1
LORTAP KCOTS LORTAP KCOTS 2 weeks ago
There was a 13G filing late Friday.
Looks like a fund bought 6,666,667 shares and is now a voting member at 9.5% ownership of MNMD.
I believe this is a very positive signal.
🏆️ 1 👍️ 2
billyjohnsonbob billyjohnsonbob 2 weeks ago
When this think blows up, you will be finished
👍️ 1 ♥️ 1
Monksdream Monksdream 2 weeks ago
Worries over potential dilution continue
💩 1 🙄 1 🚽 1 🪠 1
MomsSpaghetti MomsSpaghetti 2 weeks ago
Im probably right on this one.
👍️ 1 🫡 1
Tiger Money Tiger Money 2 weeks ago
I hope you are right!
👍️0
MomsSpaghetti MomsSpaghetti 2 weeks ago
It won't go that low. Offer was at 6.00. You'll never see those numbers. Hold. Check back in 12 months.
👍️ 1 🤑 1
Tiger Money Tiger Money 2 weeks ago
Glad I added yday. Will buy down to $4-5 if need to
💩 1 🤡 1
Tiger Money Tiger Money 2 weeks ago
Thanks!
👍️0
Tiger Money Tiger Money 2 weeks ago
Thanks!
👍️0
MomsSpaghetti MomsSpaghetti 2 weeks ago
End of 2025 or early 2026... P3 is when they will get sponsorship from big pharma... This one is a no brainer!
🌋 1 👍️ 1
WebSlinger WebSlinger 2 weeks ago
>

I think I read somewhere that it will take about 18 months, but I could be wrong.
👍️0
Tiger Money Tiger Money 2 weeks ago
When do you think phase 3 will be done? 2025? 2026? Thanks
👍️0
Tiger Money Tiger Money 2 weeks ago
I like it!
👍️0
Nelson2 Nelson2 2 weeks ago
Bought in at $8.20 this morning. Sounds great eh?
Now, for the rest of the story. Took a huge hit on the way down previously
But staying with it until the end this time

GLTA
👍️ 1 🫡 1
BefallenKnight BefallenKnight 2 weeks ago
We All Know it’s Gonna Happen
Congress has numerous banking bills for cannabis they’re just dragging their asses as they do with everything. My guess is that the election cycle will provide some mono as politicians up for election will tease federal legalization.

As for LSD, if the FDA is allowing fast-track status the DEA will be forced to get in line. Not only is it bad optics to have the DEA saying LSD is Schedule 1 while the FDA says it’s effective medicine but there are potential lawsuits from companies like MNMD for not allowing the medication to market
👍️0
BefallenKnight BefallenKnight 2 weeks ago
You Should - But Be Prepared to Sell Shares
I got super lucky, sold 30 Mar 15 10cc before the run up for $450 in premium and was able to close them yesterday for a meager $140 gain. I would’ve been happy selling the shares at 10per but I’d rather hold on to them.

I did manage some intraday scalps with cover calls over the past few days and I have a nice chunk of Jun 21 7c that I’ve already cleared some with 1000% gains so riding free money.

Oh, and I have some Mar 15 10p that I sold the other day on the drop. I’m debating whether to close those or let em ride until Friday. Either way I’ll either be assigned the shares or use the profits to buy more shares.

Like I said a few weeks ago, it’s nice to see the options premiums heating up. Great way to hedge and generate cash
👍️0

Your Recent History

Delayed Upgrade Clock